October 24, 2016 1:24 AM ET


Company Overview of Kolltan Pharmaceuticals, Inc.

Key Executives for Kolltan Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gerald McMahon Ph.D.27 RelationshipsChief Executive Officer, President and Director61
Arthur G. Altschul Jr.39 RelationshipsCo-Founder and Chairman of the Board51
Joseph P. Schlessinger Ph.D.70 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director71
Jane Pritchett V. Henderson 14 RelationshipsChief Financial & Business Officer and Senior Vice President50
Theresa M. Lavallee Ph.D.No RelationshipsSenior Vice President of Translational Medicine & Product Development50
View More Key Executives

Kolltan Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arthur G. Altschul Jr. 39 RelationshipsKolltan Pharmaceuticals, Inc.51
Gerald McMahon Ph.D. 27 RelationshipsKolltan Pharmaceuticals, Inc.61
Axel Bolte M.Sc., M.B.A. 34 RelationshipsHBM Partners Ltd.44
Joseph P. Schlessinger Ph.D. 70 RelationshipsKolltan Pharmaceuticals, Inc.71
K. Peter Hirth Ph.D. 94 RelationshipsTrovaGene, Inc.64
View All Board Members

Kolltan Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Joseph P. Schlessinger70 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$400.0K
Compensation as of Fiscal Year 2013
Kolltan Pharmaceuticals, Inc. CEO Compensation
Industry Average


Nordic Nanovector ASA Announces Board Changes
October 22, 2016 7:48 PM ET
4SC AG Announces Executive Changes
October 21, 2016 9:18 AM ET
Rosetta Genomics Ltd. Appoints Mark R. Willig as Chief Commercial Officer
October 20, 2016 12:40 PM ET
ChemoCentryx Appoints Henry A. McKinnell, Jr. to Board of Directors
October 20, 2016 12:30 PM ET
Proteon Therapeutics Inc. Appoints Paul J. Hastings as Chairman of Board of Directors
October 20, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kolltan Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.